- 2
- 0
- 约小于1千字
- 约 20页
- 2021-08-08 发布于河南
- 举报
肢瑞肥大症和巨人症 (Acromegaly and gigantism)
30 %?40 %垂体腺瘤;/;肿瘤;Table 7-6. SELECTED ONCOGENES, THEIR MODE OF ACTIVATION, AND ASSOCIATED HUMAN TUMORS;A. INCREASED GROWTH FACTOR PRODUCTION;bellar hemangioblastomas; renal cell carcinomas; angiomas and cysts of many visceral organs;Mutagenic agents;无活性的生长因*受体;弟三节
细胞信号转导调控与疾病防治;Managements
£ Specific activator or inhibitor;以细胞信号转导分子为**点的抗肿捕药物
? 蛋匂酪氨酸激酶CPTKJ抑制剂
SU5416, SU11248, CEP-701, PKC412
? 法尼基转移酶CFTaseJ抑制剂
Ras成熟必须从丰胱氨酸残基成尼及化开始
伊马誉尼flmatinibj ,上市药名叫格利维克 (GleevecJ,一种治疗慢性髓.性匂血病的药物;Managements
£ Specific activator or inhibitor;I I I I I W RNA ( dsRNA;In
原创力文档

文档评论(0)